Your AI-Trained Oncology Knowledge Connection!

News

Video

Multidisciplinary Approaches in the Treatment of Low-Grade Serous Ovarian Cancer

Author(s):

David O'Malley, MD

Dr O’Malley discusses strategies in collaborating with multidisciplinary teams for quality of life, fertility preservation, and management of treatment related side effects to optimize patient wellbeing.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!
Related Videos
Hyun-Woong Cho, MD, PhD, Department of Obstetrics and Gynecology, Korea University College of Medicine
Elizabeth Lee, MD, a gynecologic oncologist and the gynecologic oncology program's liaison to the Center for Cancer Therapeutics Innovation at Dana-Farber Cancer Institute
Taliya Lantsman, MD, a hematology/oncology fellow at Beth Israel Deaconess Medical Center
Shannon N. Westin, MD, MPH, FACOG, director, Early Drug Development, clinical medical director, professor, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, codirector, Ovarian Cancer Moonshot Program, The University of Texas MD Anderson Cancer Center
Jordyn Silverstein, MD
Rachel N. Grisham, MD
Toon Van Gorp, MD, PhD
Daniel J. George, MD, and Matthew Smith, MD, PhD, discuss ongoing research to watch in prostate cancer.
Daniel J. George, MD, and Matthew Smith, MD, PhD, discuss other key prostate cancer data presented at ASCO GU 2025.
Daniel J. George, MD, and Matthew Smith, MD, PhD, discuss data from a real-world analysis for AR inhibitors in nmCRPC.
Related Content
Gynecologic Oncology | Image Credit: © Crystal light - stock.adobe.com
March 21st 2025

Emerging ADCs, Biomarker-Driven Treatments, and Diagnostic Advancements Take Center Stage at the SGO Annual Meeting

Bradley J. Monk, MD, FACOG, FACS; Paolo Tarantino, MD
January 11th 2024

Monk and Tarantino Describe the Investigation of B7-H4 Vedotin–Directed ADCs in Gynecologic and Breast Cancers

Image credit: Crystal light - stock.adobe.com
March 18th 2025

Abemaciclib/Hormonal Therapy Combo Yields Clinical Activity in LGSOC/EEC

R. Wendel Naumann, MD
October 26th 2023

Naumann Discusses Notable Research Efforts in Endometrial Cancer

Selinexor in Endometrial Cancer
March 17th 2025

Maintenance Selinexor Extends PFS in TP53 Wild-Type Endometrial Cancer

Platinum-Resistant Ovarian Cancer | Image credit: © Sebastian Kaulitzki - stock.adobe.com
March 17th 2025

Pamiparib Plus Surufatinib Shows Modest Activity in Platinum-Resistant Ovarian Cancer